FRATES JAMES M 4
4 · Sage Therapeutics, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
FRATES JAMES M
Director
Transactions
- Award
Stock Options (Right to buy)
2025-01-03+19,154→ 19,154 totalExercise: $6.14Exp: 2035-01-03→ Common Stock (19,154 underlying)
Footnotes (1)
- [F1]The reporting person elected to receive this stock option award in lieu of payment of all cash retainers that would otherwise be paid for the reporting person's service during 2025 on the issuer's board or its committees, as permitted under the issuer's non-employee director compensation program. The stock option is granted under and subject to the terms of the Sage Therapeutics, Inc. 2024 Equity Incentive Plan. The option will vest in full on December 31, 2025, subject to the reporting person's continued service through such date.